Cited by 359

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Smoking-Dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of Chronic Obstructive Pulmonary Disease

Shaykhiev, Renat, Krause, Anja, Salit, Jacqueline, Strulovici-Barel, Yael, Harvey, Ben-Gary, O'Connor, Timothy P, Crystal, Ronald G·2009·The Journal of Immunology

Abstract

When exposed to a specific microenvironment, macrophages acquire either M1- or M2-polarized phenotypes associated with inflammation and tissue remodeling, respectively. Alveolar macrophages (AM) directly interact with environmental stimuli such as cigarette smoke, the major risk factor for chronic obstructive pulmonary disease (COPD), a disease characterized by lung inflammation and remodeling. Transcriptional profiling of AM obtained by bronchoalveolar lavage of 24 healthy nonsmokers, 34 healthy smokers, and 12 COPD smokers was performed to test the hypothesis whether smoking alters AM polarization, resulting in a disease-relevant activation phenotype. The analysis revealed that AM of healthy smokers exhibited a unique polarization pattern characterized by substantial suppression of M1-related inflammatory/immune genes and induction of genes associated with various M2-polarization programs relevant to tissue remodeling and immunoregulation. Such reciprocal changes progressed with the development of COPD, with M1-related gene expression being most dramatically down-regulated (p < 0.0001 vs healthy nonsmokers, p < 0.002 vs healthy smokers). Results were confirmed with TaqMan real-time PCR and flow cytometry. Among progressively down-regulated M1-related genes were those encoding type I chemokines CXCL9, CXCL10, CXCL11, and CCL5. Progressive activation of M2-related program was characterized by induction of tissue remodeling and immunoregulatory genes such as matrix metalloproteinase (MMP)2, MMP7, and adenosine A3 receptor (ADORA3). Principal component analysis revealed that differential expression of polarization-related genes has substantial contribution to global AM phenotypes associated with smoking and COPD. In summary, the data provide transcriptome-based evidence that AM likely contribute to COPD pathogenesis in a noninflammatory manner due to their smoking-induced reprogramming toward M1-deactivated, partially M2-polarized macrophages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.0900473

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 84

  1. 1999, Other functions, other genes: alternative activation of antigen-presenting cells., 137
  2. 1997, Pulmonary macrophages. R. G. Crystal, and J. B. West, and E. R. Weibel, and P. J. Barnes, eds., 859
  3. 1999, The macrophage in chronic obstructive pulmonary disease., S29
  4. 2007, Chronic obstructive pulmonary disease: a growing but neglected global epidemic., e112
  5. 2003, Chronic obstructive pulmonary disease: molecular and cellular mechanisms., 672
  6. 2008, Immunology of asthma and chronic obstructive pulmonary disease., 183
  7. 1995, Alveolar inflammation and its relation to emphysema in smokers., 1666
  8. 2004, The nature of small-airway obstruction in chronic obstructive pulmonary disease., 2645
  9. 2006, State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice., 494
  10. 2005, Role of CCR5 in IFN-γ-induced and cigarette smoke-induced emphysema., 3460
  11. 2007, CD8+ T cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice., 8090
  12. 2005, A distinctive alveolar macrophage activation state induced by cigarette smoking., 1383
  13. 2006, Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking., 318
  14. 1997, Use of bronchoalveolar lavage and airway brushing to investigate the human lung. R. G. Crystal, and J. B. West, and E. R. Weibel, and P. J. Barnes, eds., 371
  15. 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing., 289
  16. 1988, Deactivation of macrophages by transforming growth factor-β., 260
  17. 1993, Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10., 713
  18. 1997, Cellular responses to interferon-γ., 749
  19. 1999, Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo., 1537
  20. 2002, Shaping gene expression in activated and resting primary macrophages by IL-10., 2253
  21. 2004, Interferon-γ: an overview of signals, mechanisms and functions., 163
  22. 2005, Polarized monocyte response to cytokine stimulation., R15
  23. 2005, Regulation of macrophage phenotype by long-term exposure to IL-10., 77
  24. 2006, Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression., 7303
  25. 2007, Transcriptional profiling of the LPS induced NF-κB response in macrophages., 1
  26. 2007, Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes., 1265
  27. 2008, Activation of a TGF-β-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-β receptor II., 6553
  28. 2002, Down-regulation of macrophage CD9 expression by interferon-gamma., 891
  29. 2002, Principal component analysis
  30. 2004, Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease., 27
  31. 2008, Functional phenotype of macrophages depends on assay procedures., 215
  32. 1993, Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes., 1358
  33. 2007, CCL23 expression is induced by IL-4 in a STAT6-dependent fashion., 4335
  34. 2002, Inflammation of the airways and lung parenchyma in COPD: role of T cells., 160S
  35. 2008, Molecular pathogenesis of emphysema., 394
  36. 1999, Chronic obstructive pulmonary disease: inflammation of small airways and lung parenchyma., S21
  37. 2008, Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects., 450
  38. 1992, Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages., L471
  39. 1994, Altered cytokine regulation in the lungs of cigarette smokers., 696
  40. 2006, Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers., 428
  41. 2007, Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease., 748
  42. 2005, Respiratory tract infections: another reason not to smoke., 916
  43. 1988, Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers., 1309
  44. 2004, Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection., 1164
  45. 2008, Infection in the pathogenesis and course of chronic obstructive pulmonary disease., 2355
  46. 2001, Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease., 1618
  47. 2008, Respiratory viral infection in exacerbations of COPD., 1575
  48. 2008, Cigarette smoke selectively enhances viral PAMP- and virus-induced innate immune and remodeling responses in mice., 2771
  49. 2002, Effects of cigarette smoke on the immune system., 372
  50. 2001, Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine., 6518
  51. 2008, Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages., 27
  52. 1999, Effect of acrolein on human alveolar macrophage NF-κB activity., L550
  53. 2006, Cigarette smoke induces proinflammatory cytokine release by activation of NF-κB and posttranslational modifications of histone deacetylase in macrophages., L46
  54. 2001, Cigarette smoking depletes cells spontaneously secreting Th1 cytokines in the human airway., 121
  55. 2007, CD4-regulatory cells in COPD patients., 156
  56. 2008, Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking., 555
  57. 2008, Regulatory T cells and immune tolerance., 775
  58. 1991, Macrophage deactivation by interleukin 10., 1549
  59. 2007, A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism., 1757
  60. 2004, Tobacco smoking increases dramatically air concentrations of endotoxin., 421
  61. 2006, Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis., 233
  62. 2007, Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-κB in alveolar macrophages stimulated with TLR2 and TLR4 agonists., 6097
  63. 1996, Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators., 1019
  64. 1999, IL-10 up-regulates CCR5 gene expression in human monocytes., 241
  65. 2006, Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor., 133
  66. 2007, Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression., 1733
  67. 2000, Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema., 1081
  68. 2006, Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease., 474
  69. 2006, Developing COPD: a 25 year follow up study of the general population., 935
  70. 2006, Roger S. Mitchell lecture: chronic obstructive pulmonary disease phenotypes and their clinical relevance., 461
  71. 2008, The many “small COPDs”: COPD should be an orphan disease., 623
  72. 2008, Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages., 246
  73. 2008, A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis., 697
  74. 2000, Interferon γ induction of pulmonary emphysema in the adult urine lung., 1587
  75. 2005, Cigarette smoke-induced pulmonary emphysema in scid-mice: is the acquired immune system required?., 147
  76. 2008, CXCR3 and CCR5 chemokines in induced sputum from patients with COPD., 26
  77. 2002, Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease., 1404
  78. 2008, Peroxisome proliferator-activated receptor γactivation promotes infiltration of alternatively activated macrophages into adipose tissue., 22620
  79. 2006, Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-γ-dependent mechanism., e277
  80. 2008, Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo., 6270
  81. 2003, Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide., 4569
  82. 2006, Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC., 5825
  83. 2008, Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity., 5707
  84. 2001, Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3., 386

Cited by

Sorted by citations

See all 359

Metadata

Authors
Shaykhiev, R., Krause, A., Salit, J., Strulovici-Barel, Y., Harvey, B.-G., O'Connor, T. P., & Crystal, R. G.
Affiliations
Department of Genetic Medicine
Venue
The Journal of Immunology
Published
2009-08
Volume
183
Issue
4
Pages
2867-2883
ISSN
  • 1550-6606
  • 0022-1767
Cited by
359
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review